Conditions: Systemic Lupus Erythematosus
Keywords: Lupus SLE
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 136
Healthy volunteers: no

Brief summary:
The primary objective of this study is to evaluate the long term safety and tolerability of repeated administration of subcutaneous (SC) CEP-33457 for injection every 4 weeks over 72 weeks (18 doses) in participants with systemic lupus erythematosus (SLE) who have participated in a previous Cephalon sponsored clinical study of CEP-33457, and completed at least Visit 8 (Week 24 of that study).

Detailed description:

Arms:
arm 1: Participants will receive 200 micrograms (mcg) of CEP-33457

Interventions: intervention 1: CEP-33457
Intervention descriptions: intervention 1: CEP-33457 will be administered subcutaneously per dose specified in the arm description.

Protocol document: